Literatur
-
1 Barbui T, Finazzi G. The basis of current management strategies and future perspectives in polycythemia vera. In: Hematology 2000. American Society of Hematology. Education Program Book 61-66
-
2
Berk P D, Goldberg J D, Silverstein M N, Weinfeld A, Donovan P B, Ellis J T, Landaw S A, Laszlo J, Najean Y, Pisciotta A V, Wasserman L R.
Increased incidence of acute leukemia in polycythemia vera associated with chlorambucil therapy.
N Engl J Med.
1981;
304
441-447
-
3
Kaboth U, Rumpf K W, Lipp T, Bigge J, Nauck M, Beyer J H, Seyde W, Kaboth W.
Treatment of polycythemia vera by isovolemic large-volume erythrocytapheresis.
Klin Wochenschr.
1990;
68
18-25
-
4
Lengfelder E, Hehlmann R.
Polyzythämia vera. Aktueller Stand der Therapie.
Dtsch Med Wschr.
2000;
125
1243-1247
-
5
Messinezy M, Pearson T C.
Incidence of myelofibrosis following treatment of primary polycythaemia by venesection.
Br J Haematol.
1995;
89
228-229
-
6
Najean Y, Dresch C, Rain J D.
The very-long-term course of polycythemia: a complement to the previously published data of the polycythemia vera study group.
Br J Haematol.
1994;
86
233-235
-
7
Najean Y, Rain J D. for the French Polycythemia Study Group .
Treatment of polycythemia vera: Use of 32P alone or in combination with maintenance therapy using hydroxyurea in 461 patients greater than 65 years of age.
Blood.
1997;
89
2319-2327
-
8
Najean Y, Rain J D. for the French Polycythemia Study Group .
Treatment of polycythemia vera: the use of hydroxyurea and pipobroman in 292 patients under the age of 65 years.
Blood.
1997;
90
3370-3377
-
9
Najean Y, Rain J D.
The very long-term evolution of polycythemia vera: An analysis of 318 patients initially treated by phlebotomy or 32P between 1969 and 1981.
Semin Hematol.
1997;
34
6-16
-
10
Sterkers Y, Preudhomme C, Lai J L, Caulier M T, Wattel E, Bordessoule D, Bauters F, Fenaux P.
Acute myeloid leukemia and myelodysplastic syndromes following essential thrombocythemia treated with hydroxyurea: high proportion of cases with 17p deletion.
Blood.
1998;
91
616-622
PD Dr. Eva Lengfelder
Prof. Dr. Rüdiger Hehlmann
III. Med. Klinik Mannheim
Wiesbadener Straße 7-11
68305 Mannheim
